GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 907 filers reported holding GLAXOSMITHKLINE PLC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $365,000 | +13.4% | 8,386 | +14.7% | 0.07% | +6.3% |
| Q4 2021 | $322,000 | +51.2% | 7,311 | +30.9% | 0.06% | +34.0% |
| Q3 2021 | $213,000 | +139.3% | 5,587 | +129.7% | 0.05% | +123.8% |
| Q4 2020 | $89,000 | -71.2% | 2,432 | -68.4% | 0.02% | -92.6% |
| Q3 2018 | $309,000 | -1.0% | 7,700 | -0.2% | 0.28% | -6.6% |
| Q2 2018 | $312,000 | -24.5% | 7,713 | -27.0% | 0.30% | -28.7% |
| Q1 2018 | $413,000 | +443.4% | 10,565 | +393.2% | 0.42% | +174.2% |
| Q4 2017 | $76,000 | – | 2,142 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |